Skip to main content
. 2017 May 22;7:2252. doi: 10.1038/s41598-017-02293-z

Figure 2.

Figure 2

Shenks inhibition on bleomycin (BLM)-induced mice lung fibrosis. (A) Histological findings revealed by both H&E and Masson’s staining of lung inflammation and fibrosis in mice treated with saline and placebo, mice treated with bleomycin and placebo, and mice treated with bleomycin and Shenks or CYC. Original magnification x400. (B) Lung collagen content as determined by Sircol assay (n = 6 mice per group). (C,D,E) Collagen mRNA levels in murine lungs examined by RT-PCR. mRNA levels were calculated using a relative ratio to Gapdh. (F,G) Ctgf and TGF-β mRNA levels in murine lungs examined by RT-PCR. mRNA levels were calculated using a relative ratio to Gapdh. Values in (B,C,D,E and F) are mean ± SEM from six mice per group. *P < 0.05, **P < 0.001 when compared with mice treated with bleomycin and placebo. H&E = Hematoxylin and eosin.